scispace - formally typeset
A

Alexis Nzila

Researcher at King Fahd University of Petroleum and Minerals

Publications -  102
Citations -  5086

Alexis Nzila is an academic researcher from King Fahd University of Petroleum and Minerals. The author has contributed to research in topics: Plasmodium falciparum & Malaria. The author has an hindex of 36, co-authored 94 publications receiving 4438 citations. Previous affiliations of Alexis Nzila include John Radcliffe Hospital & Liverpool School of Tropical Medicine.

Papers
More filters
Journal ArticleDOI

Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing

Magnus Manske, +78 more
- 19 Jul 2012 - 
TL;DR: Methods for the large-scale analysis of genetic variation in Plasmodium falciparum by deep sequencing of parasite DNA obtained from the blood of patients with malaria, either directly or after short-term culture are described.
Journal ArticleDOI

Towards an Understanding of the Mechanism of Pyrimethamine-Sulfadoxine Resistance in Plasmodium falciparum: Genotyping of Dihydrofolate Reductase and Dihydropteroate Synthase of Kenyan Parasites

TL;DR: The results demonstrate that the triply mutated allele of DHFR with or without mutant DHPS alleles is associated with RI and RII resistance to PM-SD, and may be an operationally useful marker for predicting the effectiveness of PM- SD as a new malaria treatment.
Journal ArticleDOI

Polymorphisms in Plasmodium falciparum chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors That Affect Treatment Outcomes for P. falciparum Malaria After Artemether-Lumefantrine and Artesunate-Amodiaquine

Meera Venkatesan, +67 more
TL;DR: Monitoring selection and responding to emerging signs of drug resistance are critical tools for preserving efficacy of artemisinin combination therapies; determination of the prevalence of at least pfcrt K76T and pfmdr1 N86Y should now be routine.
Journal ArticleDOI

Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania

TL;DR: Analysis of parasite dhfr and dhps before and after treatment supports the view that pyrimethamine-sulfadoxine resistance in this part of Africa is primarily due to parasites with three mutations in the dhfr domain.